Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Helal F. Hetta MD"'
Autor:
Asmaa M. Zahran MD, Asmaa Nafady MD, Khaled Saad MD, Helal F. Hetta MD, Alam-Eldin M. Abdallah MD, Safwat M. Abdel-Aziz MD, Mostafa M. Embaby MD, Amir M. Abo Elgheet MD, Sanaa F. Darwish PhD, Mohamed Gamil M. Abo-Elela MD, Amira Elhoufey PhD, Khalid I. Elsayh MD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
Background: Neutrophil-to-lymphocyte ratio (NLR) was introduced as a potential inflammatory marker in sickle cell disease (SCD). This study aimed to evaluate the impact of hydroxyurea (HU) treatment on the value of NLR and some inflammatory mediators
Externí odkaz:
https://doaj.org/article/9fc234b896ba40f580f635718562a4c9
Autor:
Asmaa M. Zahran MD, Khalid I. Elsayh MD, Khaled Saad MD, Mostafa M. Embaby MD, Mervat A. M. Youssef MD, Yasser F. Abdel-Raheem MD, Shaban M. Sror MD, Shereen M. Galal MD, Helal F. Hetta MD, Mohamed Diab Aboul-Khair MD, Mohamd A. Alblihed PhD, Amira Elhoufey PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 25 (2019)
Sickle cell disease (SCD) is a genetically inherited hemolytic anemia increasingly appreciated as a chronic inflammatory condition and hypercoagulable state with high thrombotic risk. It is associated with disturbed immune phenotype and function and
Externí odkaz:
https://doaj.org/article/363de7f4fb9543e190dbd3eee057bd4f